NutrigeneAI and CUHK Professor Jack Wong Spotlighted by Major Media for Breakthrough in Vascular Regeneration Therapy Professor Jack Wong, Associate Professor at the School of Life Sciences of The Chinese University of Hong Kong (CUHK) and Co-Founder of NutrigeneAI Biotech Limited, has recently been featured in major Hong Kong media, including the Hong Kong Economic […]
NutrigeneAI Biotech Limited has been officially recognized as one of the Graduated Ventures in the Deep Tech Lab (DTL) Mentorship Program 2024–2025, distinguishing itself among over 100 participating startups and teams. This achievement reflects NutrigeneAI’s strong innovation in biotechnology and its commitment to transforming vascular healthcare through advanced science.
NutrigeneAI Biotech Limited is proud to announce the successful completion of
its second round of investment, secured from Soul Capital, a prominent venture
capital firm known for supporting innovative and emerging technologies.
NutrigeneAI Biotech Limited is excited to announce the successful completion
of its first round of investment, secured from C Cheng Holdings Limited
(01486.HK).
NutrigeneAI Biotech Limited is thrilled to announce its approval into the
prestigious Ideation Programme at Hong Kong Science and Technology Parks
Corporation (HKSTP). As part of Batch 23, NutrigeneAI joins a select group of
innovative startups dedicated to advancing technology and science.
NutrigeneAI Biotech Limited is pleased to announce its official founding. This
innovative biotechnology company is poised to revolutionize vascular health
solutions by leveraging cutting-edge technology and the combined expertise of leading vascular specialists and seasoned entrepreneurs.
In a significant advancement for cardiovascular research, Prof. Wong Wing Tak and his research team have unveiled new findings on the role of Type 2 cytokines in promoting angiogenesis in ischemic muscle via endothelial IL-4Ra signaling.
